Insulin glargine and lixisenatide Subcutaneous and M-End PE
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and M-End PE and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: brompheniramine / codeine / phenylephrine
Brand name: M-End PE, Poly-Tussin AC, TL-Hist CD
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-M-End WC
- Insulin glargine and lixisenatide Subcutaneous-M-Hist DM
- Insulin glargine and lixisenatide Subcutaneous-M-Hist PD
- Insulin glargine and lixisenatide Subcutaneous-M-M-R II
- Insulin glargine and lixisenatide Subcutaneous-M-M-R II Vaccine
- Insulin glargine and lixisenatide Subcutaneous-M-Natal Plus
- M-End PE-Insulin glargine, recombinant Subcutaneous
- M-End PE-Insulin glulisine
- M-End PE-Insulin Glulisine (Cartridges and Pens)
- M-End PE-Insulin Glulisine (Vials)
- M-End PE-Insulin glulisine Subcutaneous
- M-End PE-Insulin human inhaled Inhalation